Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Clin Cancer Res. 2008 Nov 1;14(21):7020–7027. doi: 10.1158/1078-0432.CCR-08-0541

Figure 2.

Figure 2

Differential expression of eight top ranking novel markers (CCND1, CRMP1, DDC, GABRB3, ISL1, KIF1A, PHOX2B, TACC2) and TH in 20 stage 4 NB tumors and 20 normal mononuclear cells. Tumors in gray, normal mononuclear cells in black, and transcript units in log (10) scale.